Improving the quality of cancer clinical trials (Record no. 54555)

000 -LEADER
fixed length control field 02653nam a2200421 a 4500
001 - CONTROL NUMBER
control field vtls003199760
003 - CONTROL NUMBER IDENTIFIER
control field MY-SjTCS
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20200306165334.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m u
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cn|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 100712s2008 dcua sb 000 0 eng d
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
Canceled/invalid LC control number 2008-299448
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9780309116688
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 0309116686
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)ebr10235163
039 #9 - LEVEL OF BIBLIOGRAPHIC CONTROL AND CODING DETAIL [OBSOLETE]
-- 201007121734
-- VLOAD
040 ## - CATALOGING SOURCE
Original cataloging agency CaPaEBR
Transcribing agency CaPaEBR
043 ## - GEOGRAPHIC AREA CODE
Geographic area code n-us---
050 14 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC270.8
Item number .I47 2008eb
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 362.196/994007
Edition number 22
245 00 - TITLE STATEMENT
Title Improving the quality of cancer clinical trials
Medium [electronic resource] :
Remainder of title workshop summary /
Statement of responsibility, etc. National Cancer Policy Forum, Margie Patlack and Sharyl Nass, rapporteurs.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Washington, D.C. :
Name of publisher, distributor, etc. National Academies Press,
Date of publication, distribution, etc. c2008.
300 ## - PHYSICAL DESCRIPTION
Extent xii, 124 p. :
Other physical details ill. (some col.) ;
Dimensions 23 cm.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Introduction -- New clinical trial designs. Phase 0 trials -- Adaptive trial designs -- Targeting multiple pathways with multiple drugs -- Preclinical model systems -- Molecular imaging. Current and developing methods -- Challenges of molecular imaging -- Screening for predictive markers. The challenges of clinical validation -- Bioimaging predictive markers -- Clinical translation -- Panel discussion -- Costs of clinical trials. Regulatory costs -- Patient accrual -- Global outsourcing -- Time is money -- Public-private collaborations -- Regulatory issues. Regulatory barriers to innovation -- Patient advocacy perspective -- Regulation of in vitro diagnostics -- Regulatory issues in improving cancer clinical trials -- Reports from the case study discussion groups. Adaptive trial design -- Phase 0 trials -- Imaging -- Use of proteomics/genomics to assign therapy in lung cancer -- Use of genetics/genomics to assign therapy.
529 ## -
-- TSLHHL
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE
Additional physical form available note Also available on the World Wide Web.
533 ## - REPRODUCTION NOTE
Type of reproduction Electronic reproduction.
Place of reproduction Palo Alto, Calif. :
Agency responsible for reproduction ebrary,
Date of reproduction 2009.
Note about reproduction Available via World Wide Web.
-- Access may be limited to ebrary affiliated libraries.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer
General subdivision Treatment
Geographic subdivision United States.
9 (RLIN) 264245
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical trials.
9 (RLIN) 24193
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
Source of term local
9 (RLIN) 201578
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Patlak, Margie.
9 (RLIN) 264246
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nass, Sharyl J.
9 (RLIN) 264247
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element National Cancer Policy Forum (U.S.)
9 (RLIN) 264248
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element Institute of Medicine (U.S.)
9 (RLIN) 264249
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element ebrary, Inc.
9 (RLIN) 25628
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://ezproxy.taylors.edu.my/login?url=http://site.ebrary.com/lib/taylorscollege/Doc?id=10235163
Public note An electronic book accessible through the World Wide Web; click to view
999 ## - SYSTEM CONTROL NUMBERS (KOHA)
Koha biblionumber 54555
Koha biblioitemnumber 54555
Holdings
Withdrawn status Lost status Damaged status Not for loan Date acquired Date last seen Price effective from
        2020-02-07 2020-02-07 2020-02-07